INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 203 filers reported holding INSMED INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,871,690 | -16.4% | 1,381,057 | -30.2% | 0.57% | -19.3% |
| Q2 2023 | $41,720,819 | +23.7% | 1,977,290 | -0.0% | 0.71% | +15.4% |
| Q1 2023 | $33,717,329 | -12.9% | 1,977,556 | +2.0% | 0.61% | -19.3% |
| Q4 2022 | $38,727,133 | +51.5% | 1,938,295 | +63.3% | 0.76% | +59.6% |
| Q3 2022 | $25,566,000 | +15.9% | 1,186,867 | +6.1% | 0.48% | +7.7% |
| Q2 2022 | $22,061,000 | -12.0% | 1,118,673 | +4.9% | 0.44% | +22.2% |
| Q1 2022 | $25,070,000 | -29.6% | 1,066,761 | -18.4% | 0.36% | -26.5% |
| Q4 2021 | $35,603,000 | +2.3% | 1,306,992 | +3.5% | 0.49% | +5.4% |
| Q3 2021 | $34,794,000 | +1.0% | 1,263,403 | +4.4% | 0.47% | -7.7% |
| Q2 2021 | $34,457,000 | +81.3% | 1,210,714 | +116.9% | 0.50% | +92.7% |
| Q1 2021 | $19,010,000 | -17.3% | 558,135 | -19.2% | 0.26% | -20.4% |
| Q4 2020 | $22,984,000 | – | 690,411 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 1,056,797 | $33,965,000 | 14.39% |
| Palo Alto Investors LP | 6,032,956 | $193,899,000 | 10.64% |
| Sycale Advisors (NY) LLC | 360,829 | $11,597,000 | 9.99% |
| Burrage Capital Management LLC | 165,400 | $5,316,000 | 4.20% |
| First Light Asset Management, LLC | 1,025,341 | $32,954,000 | 3.38% |
| Rubric Capital Management LP | 1,100,000 | $35,354,000 | 3.30% |
| Sofinnova Investments, Inc. | 615,143 | $19,771,000 | 1.47% |
| Endurant Capital Management LP | 144,313 | $4,638,000 | 1.37% |
| Parkwood LLC | 70,235 | $5,514,000 | 0.85% |
| Novo Holdings A/S | 430,107 | $13,824,000 | 0.69% |